Noninfectious, Severe Cryoglobulinemic Vasculitis with Renal Involvement – Safety and Efficacy of Long-Term Treatment with Rituximab

BACKGROUND: The management of nonviral cryoglobulinemic vasculitis (CV) has not been established yet. Randomized control trials are challenging to perform because of the rarity of the disease. The most promising biological therapy is rituximab (RTX), an anti-CD 20 monoclonal antibody. The aim of the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Nephrol Renovasc Dis
Asıl Yazarlar: Leśniak, Ksymena, Rymarz, Aleksandra, Lubas, Arkadiusz, Niemczyk, Stanisław
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2021
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8291846/
https://ncbi.nlm.nih.gov/pubmed/34295176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S315388
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller